Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

TELESTA THERAPEUTICS INC > Lame ducks!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by cheapinskion Jun 07, 2013 6:33pm
85 Views
Post# 21499556

RE: RE: RE: Lame ducks!

RE: RE: RE: Lame ducks!

hi givmeabrake......well, I guess it could happen but since we missed the boat a couple of times when the whole country was watching, I dont see it. Not to say I dont Want it!!!! lol Its easy to be a pessimist in these markets! have a fine weekend, cheapie

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities